{
    "SPADE_UN_15622": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_15622",
            "Peptide Name": "B18I",
            "Source": "Synthetic",
            "Family": "",
            "Gene": "Not found",
            "Sequence": "GIGKAIAKAIACIAKAIA",
            "Sequence Length": 18,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/Notavailable"
            ],
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Anticancer"
            ],
            "Target Organism": "Tumor cells:T-47D  (IC50 >148.5 µM); ZR-75-1 (IC50=10.1±1.8 µM); MCF-7/G11-TR1 (IC50=10.8±2.0 µM); MCF-7 (IC50=16.0±1.6 µM); MCF-7/G11-TR5 (IC50=16.1±4.9 µM); MDA-MB-468 (IC50=16.6±1.5 µM); SK-BR-3 (IC50=18.1±4.7 µM); MDA-MB-231 (IC50=18.6±2.4 µM)",
            "Hemolytic Activity": "Not available",
            "Cytotoxicity": "IC50 on PBMCs was = 92.0 ± 39.6 μM",
            "Binding Target": "Not available",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C76H139N21O19S",
            "Mass": 1683.11,
            "PI": 9.79,
            "Net Charge": 3,
            "Hydrophobicity": 1.39,
            "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour",
            "Comments": "may induce cell death through processes involving membrane surface blebs, loss of membrane integrity, PI internalization, LDH release and PS externalization, coupled with coordinated regulation of Src•Erk1/34 signaling and mitochondrial events.",
            "Literature": [
                {
                    "Title": "Development of a Cationic Amphiphilic Helical Peptidomimetic (B18L) As A Novel Anti-Cancer Drug Lead",
                    "Pubmed ID": "32872253",
                    "Reference": ". Cancers (Basel). 2020 Aug 28;12(9)2448.",
                    "Author": "Lyu Y, Kopcho S, Alvarez FA, Okeoma BC, Okeoma CM.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=32872253"
                }
            ],
            "Frequent Amino Acids": "AIK",
            "Absent Amino Acids": "DEFHLMNOPQRSTUVWY",
            "Basic Residues": 3,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 12,
            "Polar Residues": 11,
            "Positive Residues": 3,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_04523",
                    "Similarity": 1.0,
                    "Sequence": "KAIAFQSSPGSPVLL"
                },
                {
                    "SPADE_ID": "SPADE_N_15483",
                    "Similarity": 1.0,
                    "Sequence": "AIA"
                },
                {
                    "SPADE_ID": "SPADE_N_08436",
                    "Similarity": 0.75,
                    "Sequence": "KIGKAIKWGKAIKIGKAI"
                }
            ]
        }
    }
}